X-Vax Technology Private
X-Vax Technology is a biotechnology company focused on the preclinical and clinical development of vaccines against pathogens that cause mucosal infections such as herpes, influenza, tuberculosis and HIV, affecting hundreds of millions of people around the globe. They believe that inducing antibodies that mediate the killing of infected cells will provoke an entirely new and effective immune response вАУ so that they can finally beat these pathogens. The company was founded in 2015 and based in Jupiter, Florida.
Last Funding Type:
Series A
Last Funding Date:
2019
Headquarters:
Jupiter, Florida, United States
Industry:
PharmTech
Investor Type:
Early Stage Venture
Estimated Revenue:
Less than $1M
Total Funding:
56000000
Investors Number:
7
Employee Number:
11-50
Founded Date:
2015